What is Southern Research?
Headquartered in Birmingham, Alabama, Southern Research operates as a sophisticated not-for-profit research organization. Its operational framework is structured across four distinct, high-impact divisions: Drug Development, Drug Discovery, Energy & Environment, and Engineering. This diversified portfolio allows the organization to bridge the gap between fundamental scientific inquiry and practical, market-ready solutions. By maintaining a robust infrastructure for complex research, Southern Research serves as a vital nexus for innovation, providing the technical rigor necessary to navigate the challenges of modern biotechnology and environmental engineering. Its long-standing history of excellence has established it as a trusted authority in the scientific community, facilitating breakthroughs that address pressing global needs.
How much funding has Southern Research raised?
Southern Research has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Southern Research
PPP
Public-Private Partnership
What's next for Southern Research?
With the successful acquisition of this major enterprise-level funding, Southern Research is strategically positioned to scale its research capabilities and deepen its impact across its core divisions. The organization is expected to prioritize the expansion of its drug discovery pipeline and the enhancement of its engineering facilities, ensuring that it remains at the forefront of technological and medical innovation. As the institution moves forward, the focus will likely shift toward optimizing operational efficiencies and fostering collaborative partnerships that leverage its unique research assets. This capital injection serves as a catalyst for long-term growth, enabling the firm to sustain its mission of driving scientific progress while maintaining the high standards of integrity and excellence that have defined its legacy for over eight decades.
See full Southern Research company page
